MIG
ONCE

Mariner Investment Group’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Mariner Investment Group’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-30,000
Closed -$165K – 247
2015
Q2 		$165K Buy
+30,000
New +$1.98M 0.04% 173

Other funds holding ONCE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Mariner Investment Group's ONCE Position: Q3 2016 in Review

Mariner Investment Group sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q3 2016, closing a stake of 20,150 shares — an estimated $1.03M sold.

Mariner Investment Group first reported a position in ONCE in Q1 2015 and held it in 6 quarters. The position peaked at $2.67M in Q2 2015. 121 funds tracked by Wall St. Rank hold ONCE as of Q3 2016.

  • Mariner Investment Group reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
  • Mariner Investment Group sold 20,150 Spark Therapeutics, Inc. Common Stock shares in Q3 2016, an estimated $1.03M.
  • Mariner Investment Group first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 6 quarters.
  • Mariner Investment Group's Spark Therapeutics, Inc. Common Stock position peaked at $2.67M in Q2 2015.
  • 121 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q3 2016.

Based on Mariner Investment Group's 13F filing for Q3 2016, filed 3 Nov 2016.